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Abstract
Background: This study examined sociodemographic and tobacco-related factors of heated tobacco products
(HTPs) use among adult ever smokers in South Korea where the sales of HTPs have been rapidly increasing since
their launch in June 2017.
Methods: Before the launch of HTPs in Korea, participants comprised male ever smokers (234 current smokers and
37 quitters) who participated in the Korea National Health and Nutrition Examination Survey from 2015 to 2017
through one-to-one interview survey and agreed to participate in the follow-up surveys through telephone in
December 2017. Data were analyzed using logistic regression, to explore sociodemographic and smoking behavior-
related factors of HTPs use.
Results: Overall, 10.7% (29/271) of participants responded to using HTPs and 8.1% (22/271) were current HTPs users
at the time of the follow-up survey. Multivariate analysis showed that HTPs use is associated with middle age (36 to
49 years old) (aOR = 3.72, CI = 1.16–12.0) (vs. ≥ 50 years), higher income (4Q vs 1Q: aOR = 2.71, CI = 1.16–6.34), and
higher educational level (college or higher: aOR = 2.40, CI = 0.87–6.60). Also, vaping experience at baseline was
highly associated with HTPs use (aOR = 3.11, CI = 1.22–7.93 for the former experience; aOR = 9.14, CI = 2.34–35.6 for
current). However, smoking amount and level of motivation for smoking cessation were not found to be predictors
of future HTPs use when limited to current smokers at baseline.
Conclusions: The results showed that vaping experience regardless of current smoking behavior and higher
socioeconomic status were found to be associated with subsequent HTPs use among ever smokers. Further studies
are required to explore whether this association is causal.
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Background
Heated tobacco products (HTPs) are new technological
devices that are designed to undergo heat process
instead of combusting and release nicotine and other
volatile compounds into an inhalable aerosol [1]. An up-
dated hybrid version, “IQOS” by PMI, was first launched
in Japan in September 2014 [2]. PMI applied its HTPs to
the U.S. Food and Drug Administration (FDA) for a
modified risk tobacco product (MRTP) registration [3].
Although to prevent teenagers from accessing and
exposing this new product, stringent marketing restric-
tions were placed on HTPs in advance, the US FDA fi-
nally approved it [4].
In South Korea, three brands of HTPs have been
introduced to the market since June 2017. These prod-
ucts have drawn tremendous attention from smokers
who are concerned with their health as well as exposing
others from smoking [5]. Accordingly, the market share
of HTPs reached about 10% of total tobacco sales within
one year of their introduction [6]. As PMI claims that
IQOS emits no smoke because HTPs do not undergo
combustion, these new products can be more socially
acceptable [7, 8]. However, given the fact that these new
tobacco products are being sold globally, the debates on
health consequences are growing markedly.
Several recent studies investigated the prevalence of
HTPs use [5, 9] and their association with mental health
in South Korea [10]. Also, a few cross-sectional studies
have investigated the characteristics of awareness or use
of HTPs [2, 5, 11–13]. However, to the best of our
knowledge, no prospective studies have investigated the
factors that affect adults’ susceptibility to HTPs use.
Methods
The data of 271 male ever smokers were collected from
the Korea Centers for Disease Control and Prevention
(KCDC)-funded. This study was conducted in December
2017, six months after the launch of HTPs in South
Korea. Participants in the research were recruited from
the previous years of KNHANES baselines (2015–2017)
and agreed to participate in follow-up surveys annually
until 2020. Questions about using HTPs were “Have you
ever used HTPs?” and “In the past 30 days have you
used HTPs every day, on some days, or not at all?” [14]
The baseline questionnaire included socio-demographic
variables such as age, marital status, educational stan-
dards, and households. Other smoking-related character-
istics such as baseline smoking (former/current), vaping
status (former/current vaper (use in the past month)),
number of cigarettes per day, and motivation for quit-
ting were also considered using the transtheoretical
model [15]. The baseline data were analyzed by bivariate
analysis (chi-square test). After identifying variables that
were significantly related to HTPs use, the multivariate
logistic regression analysis was performed to examine
baseline factors related to future HTPs use.
Results
At the baseline, 234 participants responded as current
smokers (86.3%) and 37 as quitters (13.7%).
At the follow-up survey, the number of current
smokers has decreased to 76.8% (n = 208/271). More
than 40 and 10% of respondents said they had e-
cigarettes in the past year and HTPs in the past month.
Age, household income level, and vaping status reported
at the baseline survey were found to be significantly as-
sociated with future HTPs use. Several factors such as
having a higher education level, and cohabitation with
partners were noticeable in the bivariate analysis; how-
ever, were not statistically significant. The baseline
smoking status (former or current) was also not related
to future HTPs choices (p = 0.593).
Table 1 shows that people aged 36 to 49 were three
times higher than those over 50. People with higher
household income status (4Q) were three times as high
as those with the lowest income. Both former and
current vaping at baseline were highly related to the use
of HTPs. Although those with college or higher educa-
tional attainment were more likely to use HTPs, this re-
lationship was marginally significant (p = 0.09).
Discussion
HTPs sales exceeded 5% of total cigarette sales four
months after its launch and reached 10% in 11months
in South Korea [6]. At six months after IQOS was
launched, 10.7% of smokers so far responded they had
experience with HTPs. Although the smoking prevalence
among Koreans has diminished over time, new tobacco
Table 1 ORs of heated tobacco products (HTPs) use among
male ever smokers (n = 271)
% aOR 95% CI P
Age 50+ 5.1 1 (ref)
36–49 18.7 3.72 1.16–12.0 0.027
~ 35 5.9 0.61 0.14–2.62 0.51
Education ~high school 6.8 1 (ref)
College or over 14.6 2.40 0.87–6.60 0.09
*Household income 1Q ~ 3Q 8.1 1 (ref)
4Q 21.1 2.71 1.16–6.34 0.021
E-cigarette use status Never 7.3 1 (ref)
Former 13.6 3.11 1.22–7.93 0.017
Current 27.8 9.14 2.34–35.6 0.001
Data are ORs (95% CI) unless indicated otherwise. P values were calculated
after adjustment for age (categorical), education (categorial), household
income (1Q, minimun to 318,700 KW; 2Q, 318,701 to 2,000,000 KW; 3Q,
2,000,001 to 3,990,000 KW; 4Q, 3,990,001 KW to maximum), and vaping
status (categorical)
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products still have a big impact on the existing tobacco
market.
Our study found that being middle-aged (36–49 years
old), have higher incomes, higher educational attain-
ments, and prior vaping experiences are associated with
future HTPs use. These findings are consistent with
Japan’s 2018 study which showed that current smoking,
ever vaping, and higher socioeconomic status to be
related with subsequent use of current HTPs [11]. The
amount of smoking reflecting nicotine dependence and
the motive for smoking cessation were found not to be
associated with the following use of HTPs. It is pre-
sumed that smokers have chosen HTPs as alternative
tobacco products because they smell less and are less
unhealthy. While e-cigarette users tend to choose HTPs
as an aid to quit smoking, HTPs can be irrelevant to
smoking cessation efforts.
Several factors were investigated to experiment HTPs
using longitudinal data, however, some limitations
appeared on our study. First, our study analyzed only
271 male subjects and secondly, our results such as the
prevalence of each tobacco product cannot be applied to
the general population.
Conclusions
Previous vaping experience, middle-age (36–49 years
old), and higher income were found to be the major
factors of future use of HTPs among study partici-
pants, regardless of smoking status at the baseline.
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